Annika Eckhold
Gastroenterologie | Hepatologie · Dept. I
VedolizumAb in IBD - Real-world non-Interventional, ProspEctive, ObservaTional StudY to describe real-world treatment patterns in patients on vedolizumab treatment
14.07.2022This is a non-interventional prospective observational study in patients receiving Vedolizumab therapy for IBD. Sites will enroll patients with moderately to severely active IBD (UC or CD), initiating or ongoing IV induction treatment with vedolizu...
Klinische Forschung - 14.07.2022 - 31.12.2023
Automatisch geschlossen
Projektleitung: Brand Stephan
Mitarbeiter/innen: Eckhold Annika, König Marius, Krieger-Grübel Claudia
I6T-MC-AMAX
07.06.2022A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease
Klinische Forschung - 07.06.2022 - 31.12.2024
Laufend
Projektleitung: Brand Stephan
Mitarbeiter/innen: Eckhold Annika, Krieger-Grübel Claudia, König Marius
CDED Ernährungsstudie
01.06.2022The Crohn’s disease exclusion diet (CDED) for induction and maintenance of remission in Crohn’s patients with or without additional medical therapy. An open label observational trial
Klinische Forschung - 01.06.2022 - 30.12.2023
Automatisch geschlossen
Projektleitung: Krieger-Grübel Claudia
Mitarbeiter/innen: Brand Stephan, Eckhold Annika
CED-4/CEL
01.06.2022This is a double-blind, randomised, multicentre, placebo-controlled, comparative phase IIb dose-finding and efficacy trial. The trial will be conducted with four treatment groups in the form of a parallel group comparison and will serve to compare...
Klinische Forschung - 01.06.2022 - 31.12.2024
Laufend
Projektleitung: Brand Stephan
Mitarbeiter/innen: Eckhold Annika, König Marius, Krieger-Grübel Claudia, Truniger Samuel
Amgen Efavaleukin Alfa
25.04.2022A Phase 2, Multicenter, Dose-finding, Double blinded, Pla-cebo- Controlled Study to Evaluate the Safety and Effi-cacy of Efavaleukin Alfa Induc-tion Therapy in Patients with Mederatly to Severely UC
Klinische Forschung - 25.04.2022 - 31.12.2023
Automatisch geschlossen
Projektleitung: Brand Stephan
Mitarbeiter/innen: Eckhold Annika, Krieger-Grübel Claudia
Analysis of the effect of biological therapy on SARS-CoV-2-specific antibody levels following booster vaccination in patients with inflammatory bowel disease
20.01.2022This is a national multi-center cohort confirmatory study which is designed as a prospective observational trial combined with retrospective data collection. Prospective data are collected through a patient questionnaire and assessment of blood sam...
Klinische Forschung - 20.01.2022 - 30.03.2023
Automatisch geschlossen
Projektleitung: Brand Stephan
Mitarbeiter/innen: König Marius, Dütschler Joel, Krieger-Grübel Claudia, Eckhold Annika, Truniger Samuel, Frei Nicola Fabian, Albrich Werner